The association of type 2 diabetes and insulin resistance/secretion with persistent organic pollutants in two First Nations communities in northern Ontario

Diabetes and Metabolism

Volumn 39, Issue 6, 2013, Pages 497-504

  Pal, S ^a   Blais, J M ^a   Robidoux, M A ^a   Haman, F ^a,b   Krummel E ^a,c   Seabert, T A ^a   Imbeault, P ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b INSTITUT DU SAVOIR MONTFORT   (Canada)

^c Inuit Circumpolar Council of Canada   (Canada)

Author keywords

Diabetes; First Nation; Inflammation; Insulin resistance; Persistent organic pollutants

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; AROCLOR 1260; GLUCOSE; HEMOGLOBIN A1C; HEXACHLOROBENZENE; INSULIN; LINDANE; LIPID; MERCURY; MIREX; NONACHLOR; OXYCHLORDANE; POLYBROMINATED DIPHENYL ETHER; POLYBROMINATED DIPHENYL ETHER 47; POLYCHLORINATED BIPHENYL 105; POLYCHLORINATED BIPHENYL 118; POLYCHLORINATED BIPHENYL 138; POLYCHLORINATED BIPHENYL 153; POLYCHLORINATED BIPHENYL 156; POLYCHLORINATED BIPHENYL 163; POLYCHLORINATED BIPHENYL 170; POLYCHLORINATED BIPHENYL 180; POLYCHLORINATED BIPHENYL 183; POLYCHLORINATED BIPHENYL 187; POLYCHLORINATED BIPHENYL 99; POLYCHLORINATED BIPHENYL DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CANADA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HAIR; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; POLLUTANT; SMOKING; WAIST CIRCUMFERENCE;

DIABETES; DIABÈTES; FIRST NATION; INFLAMMATION; INSULIN RESISTANCE; PERSISTENT ORGANIC POLLUTANTS; POLLUANTS ORGANIQUES PERSISTANTS; PREMIÈRES NATIONS;

ADULT; ANALYSIS OF VARIANCE; CAUSALITY; DIABETES MELLITUS, TYPE 2; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; FEMALE; FOOD CONTAMINATION; HUMANS; INDIANS, NORTH AMERICAN; INSULIN; INSULIN RESISTANCE; MALE; MERCURY; OBESITY; ONTARIO; PESTICIDES; SEX DISTRIBUTION;

EID: 84887598237     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2013.01.006     Document Type: Article

References (43)

1. Young T.K., Reading J., Elias B., O'Neil J.D. Type 2 diabetes mellitus in Canada's First Nations: status of an epidemic in progress. CMAJ 2000, 163:561-566.
2. Haman F., Fontaine-Bisson B., Batal M., Imbeault P., Blais J.M., Robidoux M.A. Obesity and type 2 diabetes in Northern Canada's remote First Nations communities: the dietary dilemma. Int J Obes 2010, 34(Suppl. 2):S24-S31.
3. Imbeault P., Haman F., Blais J.M., Pal S., Seabert T., Krümmel E., et al. Obesity and type 2 diabetes prevalence in adults from two remote first nations communities in northwestern Ontario, Canada. J Obes 2011, 2011:267509.
4. Katzmarzyk P.T. Obesity and physical activity among aboriginal canadians. Obesity 2008, 16:184-190.
5. Garriguet D. Obesity and the eating habits of the Aboriginal population. Health Rep 2008, 19:21-35.
6. Lee D., Lee I., Song K., Steffes M., Toscano W., Baker B.A., et al. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999-2002. Diabetes Care 2006, 29:1638-1644.
7. Codru N., Schymura M.J., Negoita S., Rej R., Carpenter D.O. Diabetes in relation to serum levels of polychlorinated biphenyls and chlorinated pesticides in adult Native Americans. Environ Health Perspect 2007, 115:1442-1447.
8. Grandjean P., Henriksen J.E., Choi A.L., Petersen M.S., Dalgård C., Nielsen F., et al. Marine food pollutants as a risk factor for hypoinsulinemia and type 2 diabetes. Epidemiology 2011, 22:410-417.
9. Son H., Kim S., Kang J., Chang Y., Park S., Lee S., et al. Strong associations between low-dose organochlorine pesticides and type 2 diabetes in Korea. Environ Int 2010, 36:410-414.
10. Lim J., Lee D., Jacobs D.R. Association of brominated flame retardants with diabetes and metabolic syndrome in the U.S. population, 2003-2004. Diabetes Care 2008, 31:1802-1807.
11. Chang J., Chen H., Su H., Liao P., Guo H., Lee C. Simultaneous exposure of non-diabetics to high levels of dioxins and mercury increases their risk of insulin resistance. J Hazard Mater 2011, 185:749-755.
12. Lee D., Steffes M.W., Sjödin A., Jones R.S., Needham L.L., Jacobs D.R. Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes. PLoS ONE 2011, 6:15977.
13. Semeena V.S., Lammel G. The significance of the grasshopper effect on the atmospheric distribution of persistent organic substances. Geophys Res Lett 2005, 32:1-5.
14. Dewailly E., Ayotte P., Bruneau S., Laliberte C., Muir D.C.G., Norstrom R.J. Inuit exposure to organochlorines through the aquatic food chain in Arctic Quebec. Environ Health Perspect 1993, 101:618-620.
15. Reaven G.M. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995, 75:473-486.
16. Duncan B.B., Schmidt M.I., Pankow J.S., Ballantyne C.M., Couper D., Vigo A., et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2003, 52:1799-1805.
17. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
18. Csehi S., Mathieu S., Seifert U., Lange A., Zweyer M., Wernig A., et al. Tumor necrosis factor (TNF) interferes with insulin signaling through the p55 TNF receptor death domain. Biochem Biophys Res Commun 2005, 329:397-405.
19. Bastard J., Maachi M., Van Nhieu J.T., Jardel C., Bruckert E., Grimaldi A., et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 2002, 87:2084-2089.
20. Wang C., Mao X., Wang L., Liu M., Wetzel M.D., Guan K., et al. Adiponectin sensitizes insulin signaling by reducing p70 S6 kinase-mediated serine phosphorylation of IRS-1. J Biol Chem 2007, 282:7991-7996.
21. Hennig B., Meerarani P., Slim R., Toborek M., Daugherty A., Silverstone A.E., et al. Proinflammatory properties of coplanar PCBs: in vitro and in vivo evidence. Toxicol Appl Pharmacol 2002, 181:174-183.
22. Rowlands J.C., Gustafsson J. Aryl hydrocarbon receptor-mediated signal transduction. Crit Rev Toxicol 1997, 27:109-134.
23. Van Den Berg M., Birnbaum L., Bosveld A.T.C., Brunström B., Cook P., Feeley M., et al. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ Health Perspect 1998, 106:775-792.
24. Arsenescu V., Arsenescu R.I., King V., Swanson H., Cassis L.A. Polychlorinated biphenyl-77 induces adipocyte differentiation and proinflammatory adipokines and promotes obesity and atherosclerosis. Environ Health Perspect 2008, 116:761-768.
25. Mullerova D., Kopecky J., Matejkova D., Muller L., Rosmus J., Racek J., et al. Negative association between plasma levels of adiponectin and polychlorinated biphenyl 153 in obese women under non-energy-restrictive regime. Int J Obes 2008, 32:1875-1878.
26. Rignell-Hydbom A., Rylander L., Hagmar L. Exposure to persistent organochlorine pollutants and type 2 diabetes mellitus. Hum Exp Toxicol 2007, 26:447-452.
27. Robidoux M.A., Imbeault P., Blais J.M., Pal S., Seabert T., Krümmel E., et al. Traditional foodways in two contemporary Northern First Nations communities. Can J Native Stud 2012, 3. [in press].
28. Richterich R., Dauwalder H. Determination of plasma glucose by hexokinase-glucose-6-phosphate dehydrogenase method. Schweiz Med Wochenschr 1971, 101:615-618.
29. Matthews D.R., Hosker J.P., Rudenski A.S. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
30. Lee D., Lee I.N., Jin S., Steffes M., Jacobs D.R. Association between serum concentrations of persistent organic pollutants and insulin resistance among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 2007, 30:622-628.
31. Miller M.A., Amrhein J.F. Maternal transfer of organochlorine compounds in Lake Superior siscowet (Salvelinus namaycush siscowet) to their eggs. Bull Environ Contam Toxicol 1995, 55:96-103.
32. Imbeault P., Tremblay A., Simoneau J., Joanisse D.R. Weight loss-induced rise in plasma pollutant is associated with reduced skeletal muscle oxidative capacity. Am J Physiol Endocrinol Metab 2002, 282:E574-E579.
33. Turyk M., Anderson H.A., Knobeloch L., Imm P., Persky V.W. Prevalence of diabetes and body burdens of polychlorinated biphenyls, polybrominated diphenyl ethers, and p,p'-diphenyldichloroethene in Great Lakes sport fish consumers. Chemosphere 2009, 75:674-679.
34. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000, 20:1595-1599.
35. Plomgaard P., Nielsen A.R., Fischer C.P., Mortensen O.H., Broholm C., Penkowa M., et al. Associations between insulin resistance and TNF-α in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes. Diabetologia 2007, 50:2562-2571.
36. Bautista L.E., Vera L.M., Arenas I.A., Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-α) and essential hypertension. J Hum Hypertens 2005, 19:149-154.
37. Andrzejczak D., Górska D., Czarnecka E. Influence of amlodipine and atenolol on lipopolysaccharide (LPS)-induced serum concentrations of TNF-α, IL-1β, IL-6 in spontaneously hypertensive rats (SHR). Pharmacol Rep 2006, 58:711-719.
38. Yilmaz M.I., Sonmez A., Caglar K., Celik T., Yenicesu M., Eyileten T., et al. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome. Nephrology 2007, 12:147-153.
39. Kriska A.M., Saremi A., Hanson R.L., Bennett P.H., Kobes S., Williams D.E., et al. Physical activity, obesity, and the incidence of type 2 diabetes in a high-risk population. Am J Epidemiol 2003, 158:669-675.
40. Ruzzin J., Petersen R., Meugnier E., Madsen L., Lock E-, Lillefosse H., et al. Persistent organic pollutant exposure leads to insulin resistance syndrome. Environ Health Perspect 2010, 118:465-471.
41. Nurjhan N., Consoli A., Gerich J. Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus. J Clin Invest 1992, 89:169-175.
42. Imbeault P., Chevrier J., Dewailly É., Ayotte P., Després J.P., Tremblay A., et al. Increase in plasma pollutant levels in response to weight loss in humans is related to in vitro subcutaneous adipocyte basal lipolysis. Int J Obes 2001, 25:1585-1591.
43. Jørgensen M.E., Borch-Johnsen K., Bjerregaard P. A cross-sectional study of the association between persistent organic pollutants and glucose intolerance among Greenland Inuit. Diabetologia 2008, 51:1416-1422.